Single-vector inducible lentiviral RNAi system for oncology target validation

Area of Science:

• Molecular Biology
• Cancer Research
• Gene Regulation

Background:

• RNA interference (RNAi) is crucial for cancer drug target identification and validation.
• Current RNAi methods (siRNA, shRNA) have limitations in assessing cancer dependencies due to transient effects or poor in vivo utility.

Purpose of the Study:

• To develop a versatile, single-vector lentiviral Tet-inducible shRNA system (pLKO-Tet-On) for regulatable gene silencing.
• To demonstrate the system's utility in generating stable cell lines for loss-of-function studies.

Main Methods:

• A single-vector lentiviral, Tet-inducible shRNA system (pLKO-Tet-On) was constructed.
• The system was used to target polycomb group proteins (Bmi-1, Mel-18) in various cancer cell lines.
• Gene knockdown was induced and regulated by tetracycline or doxycycline.

Main Results:

• pLKO-Tet-On mediated knockdown was tightly regulated in a dose- and time-dependent manner by inducers.
• Target gene expression was fully reversible upon inducer withdrawal.
• Robust regulation was achieved for 17 additional gene products.
• The system demonstrated reversible silencing of target transcripts in vivo.

Conclusions:

• The pLKO-Tet-On system provides a robust and versatile tool for inducible and reversible RNAi.
• This system facilitates rapid identification of tumor cell dependencies.
• It is valuable for cancer drug target discovery and validation.